Sunday , August 18 2019
Breaking News
Home / BUSINESS / USFDA completes inspection at Divi’s Laboratories’ Unit-II facility in Chippada

USFDA completes inspection at Divi’s Laboratories’ Unit-II facility in Chippada

US Food and Drug Administration (USFDA) has completed inspection at Divi’s Laboratories’ Unit-II at village Chippada, Bheemunipatnam District in the state of Andhra Pradesh (AP). The inspection was conducted from June 10 to 15, 2019.

This was a general CGMP inspection by the US-FDA. The inspection has been concluded with no 483 observations.

Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.

Click & Download Udaipur Kiran App to read Latest News

Leave a Reply

Your email address will not be published. Required fields are marked *

*

Inline

Click & Download Udaipur Kiran App to read Latest News

Inline

Click & Download Udaipur Kiran App to read Latest News